BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29147899)

  • 1. Introduction/Overview.
    Ariga H; Iguchi-Ariga SMM
    Adv Exp Med Biol; 2017; 1037():1-4. PubMed ID: 29147899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Activities of DJ-1 and Its Binding Compounds Against Neurodegenerative Diseases.
    Inden M; Yanagisawa D; Hijioka M; Ariga H; Kitamura Y
    Adv Exp Med Biol; 2017; 1037():187-202. PubMed ID: 29147910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of endogenous antioxidants as a common therapeutic strategy against cancer, neurodegeneration and cardiovascular diseases: A lesson learnt from DJ-1.
    Chan JY; Chan SH
    Pharmacol Ther; 2015 Dec; 156():69-74. PubMed ID: 26432617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DJ-1 and prevention of oxidative stress in Parkinson's disease and other age-related disorders.
    Kahle PJ; Waak J; Gasser T
    Free Radic Biol Med; 2009 Nov; 47(10):1354-61. PubMed ID: 19686841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DJ-1 as a Therapeutic Target Against Cancer.
    Cao J; Chen X; Ying M; He Q; Yang B
    Adv Exp Med Biol; 2017; 1037():203-222. PubMed ID: 29147911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DJ-1 as a Biomarker of Parkinson's Disease.
    Saito Y
    Adv Exp Med Biol; 2017; 1037():149-171. PubMed ID: 29147908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative insults induce DJ-1 upregulation and redistribution: implications for neuroprotection.
    Lev N; Ickowicz D; Melamed E; Offen D
    Neurotoxicology; 2008 May; 29(3):397-405. PubMed ID: 18377993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moving beyond the Tip of the Iceberg: DJ-1 Implications in Cancer Metabolism.
    Olivo E; La Chimia M; Ceramella J; Catalano A; Chiaradonna F; Sinicropi MS; Cuda G; Iacopetta D; Scumaci D
    Cells; 2022 Apr; 11(9):. PubMed ID: 35563738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear translocation of DJ-1 during oxidative stress-induced neuronal cell death.
    Kim SJ; Park YJ; Hwang IY; Youdim MB; Park KS; Oh YJ
    Free Radic Biol Med; 2012 Aug; 53(4):936-50. PubMed ID: 22683601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Multifaceted Roles of DJ-1 as an Antioxidant.
    Raninga PV; Di Trapani G; Tonissen KF
    Adv Exp Med Biol; 2017; 1037():67-87. PubMed ID: 29147904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DJ-1 protects against dopamine toxicity: implications for Parkinson's disease and aging.
    Lev N; Barhum Y; Pilosof NS; Ickowicz D; Cohen HY; Melamed E; Offen D
    J Gerontol A Biol Sci Med Sci; 2013 Mar; 68(3):215-25. PubMed ID: 22887838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of DJ-1 in Neurodegenerative Disorders.
    Antipova D; Bandopadhyay R
    Adv Exp Med Biol; 2017; 1037():25-43. PubMed ID: 29147901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional Regulation of DJ-1.
    Takahashi-Niki K; Niki T; Iguchi-Ariga SMM; Ariga H
    Adv Exp Med Biol; 2017; 1037():89-95. PubMed ID: 29147905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental encephalomyelitis induces changes in DJ-1: implications for oxidative stress in multiple sclerosis.
    Lev N; Ickowicz D; Barhum Y; Blondheim N; Melamed E; Offen D
    Antioxid Redox Signal; 2006; 8(11-12):1987-95. PubMed ID: 17034344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DJ-1, a causative gene product of a familial form of Parkinson's disease, is secreted through microdomains.
    Tsuboi Y; Munemoto H; Ishikawa S; Matsumoto K; Iguchi-Ariga SM; Ariga H
    FEBS Lett; 2008 Jul; 582(17):2643-9. PubMed ID: 18586035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of ERK1/2 signaling pathway in DJ-1-induced neuroprotection against oxidative stress.
    Gu L; Cui T; Fan C; Zhao H; Zhao C; Lu L; Yang H
    Biochem Biophys Res Commun; 2009 Jun; 383(4):469-74. PubMed ID: 19371728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PARK7/DJ-1 in microglia: implications in Parkinson's disease and relevance as a therapeutic target.
    Lind-Holm Mogensen F; Scafidi A; Poli A; Michelucci A
    J Neuroinflammation; 2023 Apr; 20(1):95. PubMed ID: 37072827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PARK7/DJ-1 dysregulation by oxidative stress leads to magnesium deficiency: implications in degenerative and chronic diseases.
    Kolisek M; Montezano AC; Sponder G; Anagnostopoulou A; Vormann J; Touyz RM; Aschenbach JR
    Clin Sci (Lond); 2015 Dec; 129(12):1143-50. PubMed ID: 26453619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common mechanisms of onset of cancer and neurodegenerative diseases.
    Ariga H
    Biol Pharm Bull; 2015; 38(6):795-808. PubMed ID: 26027820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DJ-1 loss by glutaredoxin but not glutathione depletion triggers Daxx translocation and cell death.
    Saeed U; Ray A; Valli RK; Kumar AM; Ravindranath V
    Antioxid Redox Signal; 2010 Jul; 13(2):127-44. PubMed ID: 20014998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.